A Leading Global Regulatory Solutions & Services Company
Freyr is a trusted partner, providing end-to-end Regulatory services, across Top 20 global brands for 6 of the Forbes* Global Top 10 Fortune 500 Healthcare / Life Sciences, Mid-market $1+ Billion Bio Pharma, and Several Small-Medium, Fast Growing Life Sciences companies, CROs and Standards agencies.
Freyr is one of the few global companies to have pioneered specialized Centers of Excellence (CoEs) exclusively focusing on the entire Regulatory value-chain which are supported by rapidly growing global teams of 650+ Regulatory Professionals.
Strategic Regulatory Solutions & Services Partner to
- 9 Forbes Global Top 25 Pharma Companies
- 4 Forbes Global Top 12 Consumer Healthcare Companies
- 5 Forbes Global Top 15 Biotech Companies
- 3 Forbes Global Top 10 Medical Devices Companies
- 40+ Innovator Pharma Companies
- 20+ Bio-Tech / Bio-Similar Companies
- 35+ CROs / Consulting Companies
- 70+ Medical Device Companies
- 75+Consumer Companies (Cosmetics / Food and Food Supplements)
- 75+Generic Companies / API Manufacturers
USA, UK, CANADA, GERMANY, UAE,
MEXICO, SINGAPORE, MALAYSIA, SOUTH AFRICA, SRI LANKA,
SLOVENIA, AUSTRIA, AUSTRALIA & INDIA(Global Delivery Center)
ISO 9001 and ISO 27001 Certified
in 120+ Countries
650+ Global Regulatory
Experts and Growing
Exclusively focusing on the entire Regulatory value-chain, Freyr leverages its domain expertise and technology innovations to evolve hi-end, next generation Regulatory solutions and services that enable accelerated performance, operational excellence and significant cost and compliance benefits to clients.
Comprehensive Regulatory affairs for new product and market authorizations, Health Authority submissions, post-approvals, CMC and lifecycle management.